Filitra 20 Fortune Health Care
| Features | |
| Acne | No |
| Active Half-Life | 5-7 hours |
| Active substance | Vardenafil |
| Also known as | Levitra, Staxyn |
| Aromatization | No |
| Blood pressure | Can cause a temporary drop in blood pressure |
| Chemical name | 4-[2-Ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-9-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4-one |
| Classification | PDE5 inhibitor |
| Dosage | Men 10-20 mg/day |
| Dosage (medical) | Typically 10 mg, taken 25-60 minutes before sexual activity (adjustable based on efficacy and tolerance) |
| Dosage (sports) | Not applicable |
| Effects | Improved erectile function, enhanced blood flow |
| Formula | C23H32N6O4S |
| Half-life | 4-5 hours |
| HBR | Possible |
| Hepatotoxicity | No |
| Lab Test | Not specifically indicated |
| Main action | Enhances erectile function by increasing blood flow to the penis |
| Side effects | Headache, flushing, dyspepsia, nasal congestion, dizziness, nausea |
| Storage conditions | Store at room temperature away from moisture and heat |
| Substance class | PDE5 inhibitor |
| Trade name | Levitra, Staxyn |
| Use in sports | Not typically used in sports |
| WAREHOUSE | International Warehouse 1 |
| Water Retention | No |
| Manufacturer | Fortune Health Care |